Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120774372 | 12077437 | 2 | F | 20160203 | 20160606 | 20160215 | 20160719 | PER | US-ASTRAZENECA-2016SE12761 | ASTRAZENECA | 19745.00 | DY | F | Y | 81.20000 | KG | 20160719 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120774372 | 12077437 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | U | U | 22200 | 2 | MG | /wk | ||||||
| 120774372 | 12077437 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | U | U | 22200 | 2 | MG | /wk | ||||||
| 120774372 | 12077437 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 120774372 | 12077437 | 4 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 120774372 | 12077437 | 5 | C | PROSTATIN | ARCTOSTAPHYLOS UVA-URSI LEAFURTICA DIOICA | 1 | Oral | DAILY | 0 | ||||||||||
| 120774372 | 12077437 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 850, TWO TIMES A DAY | 0 | |||||||||||
| 120774372 | 12077437 | 7 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | 4 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120774372 | 12077437 | 1 | Type 2 diabetes mellitus |
| 120774372 | 12077437 | 2 | Type 2 diabetes mellitus |
| 120774372 | 12077437 | 3 | Hypertension |
| 120774372 | 12077437 | 4 | Hypertension |
| 120774372 | 12077437 | 5 | Blood cholesterol increased |
| 120774372 | 12077437 | 6 | Type 2 diabetes mellitus |
| 120774372 | 12077437 | 7 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120774372 | 12077437 | Diarrhoea | |
| 120774372 | 12077437 | Feeling abnormal | |
| 120774372 | 12077437 | Lipase increased | |
| 120774372 | 12077437 | Malaise | |
| 120774372 | 12077437 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120774372 | 12077437 | 1 | 201507 | 201602 | 0 | |
| 120774372 | 12077437 | 2 | 20160419 | 0 |